targeted liposome nanoparticles for small cell lung cancer (Nanosion)

N/A

Report date: 2025/01/26 17:17:30
NME

Base Information

Drug Nametargeted liposome nanoparticles for small cell lung cancer (Nanosion)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanosion Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanosion Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A